Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
View ORCID ProfileJulien Favresse, Jean-Louis Bayart, Clara David, Constant Gillot, Grégoire Wieërs, Gatien Roussel, Guillaume Sondag, Marc Elsen, Christine Eucher, Jean-Michel Dogné, View ORCID ProfileJonathan Douxfils
doi: https://doi.org/10.1101/2021.11.18.21266478
Julien Favresse
1Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium
2Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium
Jean-Louis Bayart
3Department of Laboratory Medicine, Clinique St-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium
Clara David
4Qualiblood sa, Namur, Belgium
Constant Gillot
2Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium
Grégoire Wieërs
5Department of Internal Medicine, Clinique Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium
Gatien Roussel
3Department of Laboratory Medicine, Clinique St-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium
Guillaume Sondag
1Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium
Marc Elsen
1Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium
Christine Eucher
1Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium
Jean-Michel Dogné
2Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium
Jonathan Douxfils
2Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium
4Qualiblood sa, Namur, Belgium
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author
Posted November 21, 2021.
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Julien Favresse, Jean-Louis Bayart, Clara David, Constant Gillot, Grégoire Wieërs, Gatien Roussel, Guillaume Sondag, Marc Elsen, Christine Eucher, Jean-Michel Dogné, Jonathan Douxfils
medRxiv 2021.11.18.21266478; doi: https://doi.org/10.1101/2021.11.18.21266478
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Julien Favresse, Jean-Louis Bayart, Clara David, Constant Gillot, Grégoire Wieërs, Gatien Roussel, Guillaume Sondag, Marc Elsen, Christine Eucher, Jean-Michel Dogné, Jonathan Douxfils
medRxiv 2021.11.18.21266478; doi: https://doi.org/10.1101/2021.11.18.21266478
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)